FDA Approved Medical Products for:

Neuroblastoma

The table(s) below may not be an exhaustive list of drugs or products used to treat this condition. There may be other products available that are not considered orphan products.

Generic Name Iobenguane I 123
Trade Name
(Manufacturer Name)
Adreview™
(GE Healthcare, Inc)
Indication
The FDA has approved this product to be used in this manner.
To be used in the detection of primary or metastatic pheochromocytomas or neuroblastomas as an adjunct to other diagnostic tests
More Information about this product Drug Information Portal

Generic Name dinutuximab
Trade Name
(Manufacturer Name)
Unituxin
(United Therapeutics Corporation)
Indication
The FDA has approved this product to be used in this manner.
For use in combination with granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin-2 (IL-2) and 13-cis-retinoic acid (RA), for the treatment of pediatric patients with high-risk neuroblastoma who achieve at least a partial response to prior first-line multiagent, multimodality therapy
More Information about this product Drug Information Portal